Skip to main content
Clinical Trials/CTRI/2018/10/016164
CTRI/2018/10/016164
Recruiting
Phase 3

Evaluation of efficacy of intramuscular and intravenous dexamethasone in reducing post operative swelling, pain and trismus after surgical removal of lower impacted third molars - A randomised controlled trial

Mehul Saha0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mehul Saha
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Mehul Saha

Eligibility Criteria

Inclusion Criteria

  • 1\. Impacted mandibular third molars with Pell and Gregory classification Class II or III and Level B or C on the radiograph and Pederson difficulty index of Moderately Difficult (5\-6\).
  • 2\. Subjects would be healthy individuals, 18 years of age or older and with AHA score I.
  • 3\. Subjects who would not require any prophylactic antibiotics or analgesics.
  • 4\. Subjects who would be travelling within 10km radius of the hospital.

Exclusion Criteria

  • 1\. Patients with signs of active infection (fever/pus discharge/palpable and painful lymph nodes).
  • 2\. Immunocompromised subjects.
  • 3\. Medically compromised subjects (ASA score II, III, IV, V)
  • 4\. History of allergy to the drug used.
  • 5\. Pregnancy or lactation.
  • 6\. Those who use other drugs during the observation period (anticoagulants/antiepileptics/steroids/antifungals/antibiotics/analgesics).
  • 7\. Those who refuse to take part in the study or come for regular follow up.

Outcomes

Primary Outcomes

Not specified

Similar Trials